The Challenge of Calcium

Calcium is one of the biggest challenges you face with today’s complex patients. It’s good to know that whatever type of calcified lesion you’re treating, orbital atherectomy is the single solution you need to get from calcified to compliant, safely and efficiently.

See the Unique Dual-Action Technology of Diamondback®

Real-world Case Studies using Diamondback 360

PAD: Retrograde Treatment SFA CTO
Mahir D. Elder, MD
Dr. Mahir D. Elder used orbital atherectomy in the treatment of a superficial femoral artery (SFA) chronic total occlusion (CTO).

Read More

CAD: Tight Lesion Treatment Of LAD
Emmanouil S. Brilakis, MD
Dr. Emmanouil Brilakis used orbital atherectomy in the treatment of a severely calcified LAD.

Read More

PAD: Treatment of Multilevel Disease to Avoid Amputation
Tarpan R. Patel, MD
Dr. Tarpan R. Patel used the Diamondback 360® Peripheral Orbital Atherectomy System Exchangeable Series with GlideAssist® in the treatment of multi-level disease to avoid amputation.

Read More

CAD: 99% Stenosis – Right Proximal Coronary Artery
Dean M. Ferrera, DO, FACC, FSCAI
Dr. Dean M. Ferrera performed a distal RCA revascularization using orbital atherectomy enabling PTCA and multiple stents.

Read More

PAD: Radial Artery Access Treatment of CFA
William Hull, D.O.
Dr. William Hull used orbital atherectomy via radial artery access in the treatment of severe claudication and stenosis in the left common femoral artery.

Read More

Learn More about our Portfolio of Products

Education Highlights





Regional & National



Intermediate: An
Introduction to Therapy Technology.
Taught by Certified Instructors

Advanced: Expanding Skills and Techniques. Best Practices

Masters: Leading Experts.
Clinical Updates. Latest



OAS Certification

Fellows Course &
Milestones Calendar

Online Learning Modules
& Focused Webinars


OAS Certification

Case Library

CSIQ Learning Management

Peer-to-Peer Webinars

Live Case Broadcasts

​For more information on CSI’s Professional Education Program, click here:

Stay In Touch

  1. Shammas NW, Lam R, Mustapha J, Ellichman J, et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial. J Endovasc Ther. 2012 Aug;19(4):480-8
  2. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005 Jan 18;45(2):312-5.
  3. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. Circulation. 1992; 86(1):64-70.
  4. Adams GL, Khanna PK, Staniloae CS, et al. Optimal techniques with the Diamondback 360° System achieve effective results for the treatment of peripheral arterial disease. J Cardiovasc Transl Res. 2011 Apr;4(2):220-9.
  5. Krishnan P, Martinsen BJ, Tarricone A, et al. Minimal Medial Injury After Orbital Atherectomy. J Endovasc Ther. 2017 Feb;24(1):167-168.
  6. Zheng Y, Belmont B, Shih AJ. Experimental investigation of the abrasive crown dynamics in orbital atherectomy. Med Eng Phys. 2016 Jul;38(7):639-647.
  7. Bosiers M, Deloose K, Callaert J, et al. 4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial. J Endovasc Ther. 2013 Dec;20(6):746-56.
  8. Lodha A. REACH PVI Clinical Study Results. Presented at NCVH 2020.
  9. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012 Dec 18;60(24):2481-9.
  10. Thakor AS, Alshammari MT, Liu DM, et al. Transradial Access for Interventional Radiology: Single-Centre Procedural and Clinical Outcome Analysis. Can Assoc Radiol J. 2017 Aug;68(3):318-327.
  11. Giannopoulos S, Secemsky EA, Mustapha JA, et al. Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia. J Endovasc Ther. 2020 Oct;27(5):714-725.
  12. CSI Data on File
  13. Adams GL, et al. J Vasc Surg. 2019;70(5):e188-e189.
  14. Dattilo R, Himmelstein SI, Cuff RF. The COMPLIANCE 360° Trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol. 2014;26(8):355-60.
  15. Chambers J, et al. JACC Cardiovasc Interv. 2014;7(5):510-518.
  16. Shlofmitz E, et al. Expert Rev Med Devices. 2017;14(11):867-879.
  17. Yamamoto M, et al. Catheter Cardiovasc Interv. 2019;93(7):1211-1218.
  18. Kini A, et al. Catheter Cardiovasc Interv. 2015;86(6):1024-1032.
  19. Shlofmitz E, et al. Interv Cardiol. 2019;14(3):169-173.
  20. CSI Data on File.
  21. Lee, et al. J Interven Cardiol. 2018;31:15-20.
  22. CSI Data on file. In the ORBIT II study, the OAS was inserted and activated in 434 subjects, but in 2 cases, the OAS was unable to cross the lesion.
  23. Vinardell, TCT2020, No. 165.
  24. Lee M, et al. Cardiovasc Revasc Med. 2017 Jun;18(4):261-264.
  25. Lee MS, et al. Coronary Orbital Atherectomy. 2018. P. Lanzer (ed.), Textbook of Catheter-Based Cardiovascular Interventions, Note: These data are from different studies that differ in terms of treatment protocols, inclusion/exclusion criteria, patient populations, among other things. Physicians should draw their own conclusions based on the findings in the respective publications.